Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00012103 · ClinicalTrials.gov registry record · NA

Computed Tomography for Early Detection of Cancer in Women Who Are at Risk for Lung Cancer

A NA study, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase

NCT00012103: Completed NA study, sponsored by NYU Langone Health.

NCT00012103 is a NA study that has completed, run by NYU Langone Health. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00012103, a NA study, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase

Study Summary

RATIONALE: Imaging procedures such as computed tomography may improve the ability to detect lung cancer earlier. PURPOSE: Screening and diagnostic study of computed tomography in women who are at risk for lung cancer.

Interventions

  • OTHER sputum cytology
  • OTHER screening questionnaire administration
  • PROCEDURE bronchoscopy
  • PROCEDURE bronchoscopic and lung imaging studies
  • OTHER bronchoalveolar lavage

Trial Details

FieldValue
Start Date 1999-09
Phase NA
NYU Langone Health

1,164 total trials

What the finished NCT00012103 record still lists

NCT00012103 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.

The record links to 0 conditions, and to 5 interventions - of which sputum cytology is the first listed.

NCT00012103 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00012103 about?

NCT00012103 is a clinical study titled "Computed Tomography for Early Detection of Cancer in Women Who Are at Risk for Lung Cancer". RATIONALE: Imaging procedures such as computed tomography may improve the ability to detect lung cancer earlier. PURPOSE: Screening and diagnostic study of computed tomography in women who are at risk for lung cancer.

What is the current status of trial NCT00012103?

This trial is currently completed. It is a NA study. The study started on 1999-09.

What interventions are being tested in trial NCT00012103?

The interventions under investigation include: sputum cytology (OTHER), screening questionnaire administration (OTHER), bronchoscopy (PROCEDURE), bronchoscopic and lung imaging studies (PROCEDURE), bronchoalveolar lavage (OTHER).

Who is sponsoring clinical trial NCT00012103?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Learn More About Clinical Trials

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00012103, the US trial registry maintained by the National Library of Medicine. NCT00012103 (unsized enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.